AMBRA1 E3 酶适配器调节了 D 环素的稳定性
Andrea C Chaikovsky1,2, Chuan Li3, Edwin E Jeng2
1Department of Pediatrics, Stanford University, Stanford, CA, USA.
Nature
|April 15, 2021
概括
自和贝克林1调节器1 (AMBRA1) 通过标记其降解来控制环林D水平. 失去AMBRA1会增加D环,促进癌症的生长,降低对CDK4/ 6抑制剂的敏感性.
科学领域:
- 细胞生物学
- 分子生物学
- 癌症学
背景情况:
- 细胞分裂启动整合了细胞输入,D型循环素 (D循环素) 将这些与DNA复制联系起来.
- 由于无法控制的细胞增殖,增加的cyclin D-CDK4/ 6活性与癌症有关.
- 调节D环素水平的机制尚不完全理解.
研究的目的:
- 确定循环D降解的关键调节剂.
- 研究AMBRA1在细胞周期控制和癌症中的作用.
- 了解AMBRA1对CDK4/ 6抑制剂反应的影响.
主要方法:
- 全基因组基因查以确定CDK4/6抑制反应的调节剂.
- 细胞和小鼠模型评估AMBRA1损失的影响.
- 生物化学试验以阐明环素D降解的机制.
主要成果:
- 确定AMBRA1是循环D降解的主要调节剂.
- 失去AMBRA1会导致循环D水平升高,促进细胞增殖并降低对CDK4/ 6抑制的敏感性.
- AMBRA1 作为 CUL4 E3 连接酶复合物的基质受体,介导环素 D 无处不在和蛋白质体降解.
结论:
- AMBRA1是细胞D环素水平的关键调节剂.
- 在小鼠中,AMBRA1损失增加了肺腺癌的生长.
- 低AMBRA1水平与肺腺癌患者的存活率较低相关,这表明AMBRA1在癌症的发展和治疗反应中起作用.
更多相关视频
10:54Studying Proteolysis of Cyclin B at the Single Cell Level in Whole Cell Populations
Published on: September 17, 2012
10.7K
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
14.6K
相关概念视频
Anaphase Promoting Complex
3.0K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
Positive Regulator Molecules
6.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
6.0K
Positive Regulator Molecules
117.0K
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
117.0K
Separation of Sister Chromatids
4.0K
At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
At the onset of anaphase, separase, a proteolytic enzyme, is...
4.0K
M-Cdk Drives Transition Into Mitosis
5.9K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.9K
Inhibition of Cdk Activity
5.2K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.2K
